Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    " March 25, 2009":" April 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
Conditions: Endothelial Function;   Lipids;   Insulin Resistance;   Inflammation;   HIV Infections
Intervention: Drug: Etravirine
22 Completed
Has Results
Atazanavir and Lamivudine for Treatment Simplification
Condition: HIV Infections
Interventions: Drug: Lamiduvine (Epivir);   Drug: Atazanavir (Reyataz);   Drug: Ritonavir (Norvir)
23 Completed Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania
Conditions: Malaria, Falciparum;   HIV Infections
Intervention: Drug: Artemether-lumefantrine (AL)
24 Completed
Has Results
Triomune Bioequivalence With Innovators
Condition: HIV/AIDS
Interventions: Drug: Triomune;   Drug: Zerit/Epivir/Viramune
25 Completed Hepatitis B Vaccination (HBV) in HIV Infected Children
Condition: HIV Infections
Interventions: Biological: Intradermal HBV 1 course;   Biological: Intramuscular HBV I course
26 Completed
Has Results
Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
Conditions: Anxiety Disorders;   HIV Infections
Intervention: Drug: Escitalopram
27 Completed Raltegravir and Atazanavir Dosing Strategy Study
Condition: HIV Infection
Intervention: Drug: atazanavir plus raltegravir
28 Completed Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
Conditions: Opioid Dependency;   HIV Infections
Interventions: Drug: Fosamprenavir/Ritonavir;   Drug: Darunavir/Ritonavir;   Drug: Rifampin;   Drug: Rifabutin;   Drug: Buprenorphine
29 Completed Dose Reduction of Lopinavir in Children
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir standard dose According to WHO simplified dosing table;   Drug: Lopinavir/ritonavir low dose ( 70% of WHO recommended dosing table)
30 Completed Maraviroc Immune Recovery Study
Condition: HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
31 Completed
Has Results
Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy
Conditions: HIV;   Hyperlipidemia;   Hypertriglyceridemia;   HIV Infections
Intervention: Drug: raltegravir
32 Completed Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
Condition: HIV Infections
Interventions: Biological: RotaTeq vaccine;   Biological: RotaTeq vaccine placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years